Intervention

Amlodipine 5mg

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 15 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials15

Recruiting1

Common conditions17

Lead sponsors shown11

Clinical trials

15 shown

Intervention for High-normal Blood Pressure in Adults With Type 2 DiabetesNCT03264352 · 2018-02-01

Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic HypertensionNCT05165251 · 2022-01-04

Treatment of Early Hypertension Among Persons Living With HIV in HaitiNCT04692467 · 2021-02-26

Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential HypertensionNCT04554303 · 2020-10-28

Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without DiabetesNCT03978884 · 2019-06-01

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV DiseaseNCT03666351 · 2018-10-18

CKD-330 Phase 3 Trial in Amlodipine Non-responderNCT02586311 · 2016-01-01

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate DrugsNCT02548286 · 2015-08-01

Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related HypertensionNCT04474899 · 2015-06-24

Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyNCT02651870 · 2015-04-22

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate MonotherapyNCT02368665 · 2014-12-01

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential HypertensionNCT02944734 · 2014-09-01

A Dose Selection Trial of CKD-330 in Patients With Essential HypertensionNCT02206165 · 2014-03-01

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionNCT02059616 · 2014-02-01

A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual ComponentsNCT00819104 · 2008-11-01

Common conditions

Hypertension6 Essential Hypertension5 Adverse Event1 Aortic Regurgitation1 Aortic Stenosis1 Blood Pressure1 Cardiovascular Risk Factor1 Diabetes Mellitus1 Diabetes Mellitus, Type 21 HIV/AIDS1 Isolated Systolic Hypertension1 Left Ventricular Hypertrophy1 LVM1 Obesity1 Pre Hypertension1 Prehypertension1 Primary Hypertension1

Leading sponsors

Chong Kun Dang Pharmaceutical 4 HK inno.N Corporation 2 Ahn-Gook Pharmaceuticals Co.,Ltd 1 AstraZeneca 1 Hanmi Pharmaceutical Company Limited 1 Royal Perth Hospital 1 Shanghai Jiao Tong University School of Medicine 1 Shin Poong Pharmaceutical Co. Ltd. 1 The University of The West Indies 1 Weill Medical College of Cornell University 1 XueQing Yu 1

Trial status mix

COMPLETED8

UNKNOWN5

RECRUITING1

WITHDRAWN1

Phase mix

PHASE46

PHASE24

PHASE33

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.